-transparent.png){kind=logo}
Nine anti-herpes compounds, idoxuridine (IDU), bromovinyldeoxyuridine (BVDU), bromovinylarabinofuranosylurasil (BVaraU), carbocyclic bromovinyldeoxyuridine (C-BVDU), chloroethyldeoxyuridine (CEDU), acyclovir (ACV), dihydroxypropoxymethylguanine (DHPG), adenine arabinoside (Ara-A), and phosphonoformate (PFA) were examined for their inhibitory activities against the replication of twenty-six newly isolated clinical strains of varicella-zoster virus (VZV) in human embryonic fibroblast cell cultures. The order of (decreasing) efficacy was: BVaraU greater than BVDU greater than or equal to C-BVDU greater than CEDU greater than or equal to IDU greater than ACV greater than Ara-A greater than DHPG greater than PFA. There was little variation in the susceptibility of the 26 VZV strains to each particular compound, except for one strain which was resistant to IDU.
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
April 1995,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
April 1984,
Antimicrobial agents and chemotherapy,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
January 2010,
Voprosy virusologii,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
June 2011,
Antiviral research,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
February 1991,
Antimicrobial agents and chemotherapy,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
April 1984,
Antimicrobial agents and chemotherapy,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
November 1998,
Ugeskrift for laeger,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
February 1982,
Antimicrobial agents and chemotherapy,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
July 1991,
Antimicrobial agents and chemotherapy,
M Baba, and
K Konno, and
S Shigeta, and
E De Clercq
September 1989,
Antiviral research,
